Clinical Trial Update: Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Clinical trial evaluating whether replacing warfarin with rivaroxaban, with or without vitamin K2, affects vascular calcification in hemodialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Vascular Calcification

Drugs mentioned

• Rivaroxaban (rivaroxaban)
• Vitamin K2 (menaquinone)
• Warfarin (warfarin)

Snippet

Sponsor: Onze Lieve Vrouw Hospital | Conditions: Vascular Calcification | Phase 4 | Status: COMPLETED